₹-3.60
(Market cap
₹126 Cr
Revenue (TTM)
₹98 Cr
P/E Ratio
34.1
P/B Ratio
2.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
10.6 %
-
ROCE
10.1 %
-
Industry P/E
33.65
-
EV/EBITDA
17.5
-
Debt to Equity
1.5
-
Book Value
₹48.1
-
EPS
₹4.7
-
Face value
10
-
Shares outstanding
10,127,435
10 Years Aggregate
CFO
₹69.77 Cr
EBITDA
₹81.50 Cr
Net Profit
₹30.29 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Godavari Drugs
| 61.9 | -0.6 | 45.6 | 31.4 | 15.7 | 15.7 | 11.8 |
|
BSE Healthcare
| 9.5 | 9.4 | 9.8 | 12.1 | 27.6 | 14.5 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Godavari Drugs
| -30.6 | 20.9 | -5.1 | 51.5 | 62.5 | 120.1 | -31.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Godavari Drugs
|
124.4 | 125.9 | 98.2 | 3.7 | 8.1 | 7.9 | 34.1 | 2.6 |
| 3,248.2 | 40,546.6 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 38.4 | 9.0 | |
| 8,695.5 | 21,719.0 | 2,177.5 | 200.9 | 11.3 | 26.5 | 108.1 | 26.1 | |
| 2,038.2 | 15,490.4 | 2,187.2 | 649.7 | 31.5 | 19 | 24.2 | 4.3 | |
| 1,336.2 | 18,531.3 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.9 | 5.1 | |
| 2,171.6 | 34,908.7 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.2 | 8.4 | |
| 4,785.4 | 21,859.4 | 2,519.7 | 722.4 | 33.6 | 18.8 | 30.3 | 5.2 | |
| 5,340.5 | 8,874.7 | 1,348.5 | 293.5 | 28.1 | 50.7 | 30.2 | 12.7 | |
| 472.5 | 9,248.1 | 1,432.0 | 149.0 | 19.1 | 7.9 | 61.6 | 3.7 | |
| 1,153.6 | 10,633.5 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Godavari Drugs
Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. It offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid,... enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. The company also provides loan license and contract manufacturing services. It serves the life science industry. The company was incorporated in 1987 and is based in Secunderabad, India. Read more
-
Incorporated
1987
-
Chairman
Ghanshyam Jaju
-
Managing Director
Mukund Kakani
-
Headquarters
Secunderabad, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsClarification On Price Movement
18-Apr-2026Clarification sought from Godavari Drugs Ltd
17-Apr-2026No News & Announcements are available.
FAQs for Godavari Drugs
What is the current share price of Godavari Drugs Ltd Today?
The share price of Godavari Drugs Ltd is ₹124.35 (BSE) as of 19-May-2026 IST. Godavari Drugs Ltd has given a return of 15.69% in the last 3 years.
What is the current PB & PE ratio of Godavari Drugs Ltd?
The P/E ratio of Godavari Drugs Ltd is 34.11 times as on 19-May-2026, a 1 premium to its peers’ median range of 33.65 times.
The P/B ratio of Godavari Drugs Ltd is 2.58 times as on 19-May-2026, a 44 discount to its peers’ median range of 4.59 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
15.04
|
1.52
|
|
2024
|
12.61
|
1.80
|
|
2023
|
15.07
|
1.71
|
|
2022
|
9.39
|
1.66
|
|
2021
|
8.35
|
1.41
|
What is the 52 Week High and Low of Godavari Drugs Ltd?
The 52-week high and low of Godavari Drugs Ltd are Rs 134.50 and Rs 69.70 as of 19-May-2026.
What is the market cap of Godavari Drugs Ltd?
Godavari Drugs Ltd has a market capitalisation of ₹ 126 Cr as on 19-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Godavari Drugs Ltd?
Before investing in Godavari Drugs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.